Stromelysin-3: A potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma

American Journal of Dermatopathology

Volumn 20, Issue 2, 1998, Pages 140-142

  Thewes, Matthias ^a   Worret, W I ^a   Engst, R ^a   Ring, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Desmoplastic trichoepithelioma; Immunohistochemistry; Matrix metalloproteinase; Morphealike basal cell carcinoma; Stromelysin 3

Indexed keywords

BIOCHEMICAL MARKER; FORMALDEHYDE; PARAFFIN; STROMELYSIN;

ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHEA; PRIORITY JOURNAL; TRICHOEPITHELIOMA; TUMOR DIFFERENTIATION;

CARCINOMA, BASAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 11; METALLOENDOPEPTIDASES; NEOPLASMS, BASAL CELL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0031970914     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199804000-00006     Document Type: Article

References (12)

1. Ackerman A, Viragh PA, Chongchitnant N. Neoplasms With Follicular Differentiation. Philadelphia: Lea and Febiger, 1993;574-602.
2. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in siromal cells of breast carcinomas. Nature 1990;348:699-704.
3. Thewes M, Worret W-I, Engst R, Ring J. Immunohistochemical characterization of the new matrix metalloproteinase stromelysin-3(ST-3). J Invent Dematol 1997;109:421.
4. Wagner SN, Ruhri C, Kunth K, et al. Expression of stromelysin-3 in the stromal elements of the human basal cell carcinoma. Diagn Mol Pathol 1992;3:200-5.
5. Basset P, Wolf C, Chambon P. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat 1993;24:185-93.
6. Takei Y, Fukushiro S, Ackerman AB. Criteria for histologic differentiation of desmoplastic trichoepithelioma (sclerosing epithelial hamartoma) from morphea-Iike basal-cell carcinoma. Am J Dermatopathol 1985;7:207-21.
7. Santavicci M, Noel A, Chenard MP, et al. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semiquantitative immunohistochemistry. Int J Cancer 1995;64:336-41.
8. Cordell JL, Falini B, Erber WN, et al. Immunencymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase anti-alkaline phosphatase (APAAP). J Histochem Cytochem 1984;32:219-29.
9. Elder D, Elenitsas R, Jaworsky C, Johnson B. Lever's Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven, 1997:685-746.
10. MacDonald DM, Jones EW, Marks R. Sclerosing epithelial hemaloma. Clin Exp Dermatol 1977;2:153-60.
11. Brownstein M, Shapiro L. Desmoplastic trichoepithelioma. Cancer 1977;40:2979-86.
12. Rouyer N, Wolf C, Chenard MP, et al. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994;14:269-75.